oppalerts.com →
Dermatology Groups

Eczema Flare Manager

Knowledge Graph Entities
Dominant · SE Outbound Links ρ=0.405

AI recommendation signal analysis across 297 domains for the Eczema Flare Manager persona in Dermatology Groups.

297Domains Tracked
Eczema Flare Manager_persona.report
EntityScore
Mayo Clinic
60.0
Cleveland Clinic
60.0
Human Resource Management Review
60.0
American journal of contact dermatitis : official journal of the American Contact Dermatitis Society
54.3
National Institute for Occupational Safety and Health
51.7
Want a custom AI visibility audit for Dermatology Groups?

This report tracks how AI models and search engines recommend companies across 100 industries. If you want the same analysis run specifically against your own site and competitors, get in touch.

Get in touch
About This Report

How to use this page

Persona view: this page is scoped to this persona's queries alone.
Use Case

Check your knowledge-graph footprint

Wikidata is the structured knowledge graph behind Wikipedia, search engines, and many AI systems. If the graph does not know a brand, machines have less to anchor an answer on. See which entities carry this segment's topics and brands, and whether its top domains have an entity at all.

How It's Calculated

Where the numbers come from

We scan every Wikidata entity record (labels, descriptions, property values) for this segment's topic phrases and brand hostnames. Entity records are short structured data, so counts run far smaller than article text. Coverage checks which entities claim each domain as an official website.

Overview

What's on this page

Top-entity charts, the full entity table, and a knowledge-graph coverage check for this segment's most LLM-recommended domains.

Segment Totals

Knowledge graph at a glance

How much of the Wikidata knowledge graph touches Eczema Flare Manager. Entity records are short structured data (labels, descriptions, property values), so these counts run far smaller than Wikipedia article text; what matters is which entities show up, not raw volume.

41K
Entities With Topic Matches
4,911
Entities Mentioning Brands
42K
Topic Phrase Matches
5,261
Brand Mentions
Top Domains

Knowledge graph coverage

Whether a Wikidata entity claims each of this segment's most LLM-recommended domains as its official website. A brand without an entity is invisible to systems that navigate the web through the knowledge graph.

17 of 25 top domains for Eczema Flare Manager have a knowledge-graph entity.

Wikidata

Top knowledge-graph entities

The entity records where Eczema Flare Manager's brands and topics appear. Brand Mentions is the more reliable single ranking here; broadly used phrases can surface large unrelated entities in the topic view. Blended merges the two on a log scale (brand mentions weighted higher, 0 to 100). Bars and entity names link to the record; entities with no label show their Wikidata ID. The table follows the selected view.


EntityBlendedBrand MentionsTopic Matches
Mayo Clinic60.040
Cleveland Clinic60.040
Human Resource Management Review60.040
American journal of contact dermatitis : official journal of the American Contact Dermatitis Society54.313
National Institute for Occupational Safety and Health51.730
Q22988351.730
The Cigna Group51.730
Brain and Language51.730
Epilepsy Currents51.730
Virology51.730
Applied Mathematics and Computation51.730
Advances in Virus Research51.730
Advances in Parasitology51.730
American Journal of Managed Care51.730
Vital and health statistics. Series 21, Data on natality, marriage, and divorce51.730
Vital and health statistics. Series 5, Comparative international vital and health statistics reports51.730
Harvard men's health watch51.730
Harvard women's health watch51.730
Chronic Diseases and Translational Medicine51.730
World Journal of Otorhinolaryngology-Head and Neck Surgery51.730
Office of Readiness and Response51.730
Clinical trial NCT0759738251.730
Clinical trial NCT0758582551.730
Clinical trial NCT0757161651.730
Clinical trial NCT0757162951.730
Clinical trial NCT0761103251.730
Wave Motion41.020
Ultrasonics Sonochemistry41.020
University of Pennsylvania41.020
Massachusetts General Hospital41.020
Nucleic Acids Research41.020
United Methodist Church41.020
Clinical Genitourinary Cancer41.020
Journal of Economic Theory41.020
Blood41.020
Tetrahedron Letters41.020
Nuclear Physics41.020
The University of Texas MD Anderson Cancer Center41.020
Trends in Cell Biology41.020
Intelligence41.020
Journal of Operations Management41.020
Brachytherapy41.020
Mechanisms of Ageing and Development41.020
Trends in Cardiovascular Medicine41.020
Seminars in Cancer Biology41.020
Journal of Crystal Growth41.020
Field Crops Research41.020
Cardiovascular Pathology41.020
Biophysical Journal41.020
Physica C41.020
Computer Communications41.020
Robotics and Autonomous Systems41.020
Marine Micropaleontology41.020
Comptes Rendus. Biologies41.020
Mathematical Biosciences41.020
International Journal of Medical Informatics41.020
Postharvest Biology and Technology41.020
Nuclear Physics A41.020
Toxicological Sciences41.020
Toxicology and Applied Pharmacology41.020
Advances in Agronomy41.020
Cancer Detection and Prevention41.020
Cancer Radiothérapie41.020
Epi Info41.020
Microelectronic Engineering41.020
Optical Switching and Networking41.020
Journal of Communication Disorders41.020
Agricultural Systems41.020
Applied Catalysis A: General41.020
Applied Clay Science41.020
International Review of Cytology41.020
International Journal of Obstetric Anesthesia41.020
Nuclear Physics B41.020
Annales pharmaceutiques françaises41.020
Coordination Chemistry Reviews41.020
Food Chemistry41.020
Journal of Molecular Structure41.020
Journal of the American Society for Mass Spectrometry41.020
Electrochemistry Communications41.020
Fuel Processing Technology41.020
National Education Association41.020
Advances in Cancer Research41.020
Journal of Fluorine Chemistry41.020
Journal of Pharmaceutical Sciences41.020
Microporous and Mesoporous Materials41.020
Progress in Solid State Chemistry41.020
Radiation Physics and Chemistry41.020
Vibrational Spectroscopy41.020
Physiology & Behavior41.020
Vacuum41.020
Computers and Electronics in Agriculture41.020
Advances in Mathematics41.020
American Journal of Preventive Medicine41.020
American Journal of Translational Research41.020
Biomedical Optics Express41.020
Blue Cross Blue Shield Association41.020
Boston Medical Center41.020
Brain Research41.020
China Economic Review41.020
ClinicalTrials.gov41.020
Cultural Diversity and Ethnic Minority Psychology41.020
dbSNP41.020
Duke University Health System41.020
Early Childhood Research Quarterly41.020
Everyday Health41.020
Experimental Hematology41.020
Geochimica et Cosmochimica Acta41.020
H. Lee Moffitt Cancer Center & Research Institute41.020
Journal of Memory and Language41.020
Journal of Second Language Writing41.020
Journal of Sound and Vibration41.020
Journal of the Academy of Nutrition and Dietetics41.020
Laboratory Investigation41.020
Learning and Individual Differences41.020
Magnetic Resonance Imaging41.020
Museum Management and Curatorship41.020
Personality and Individual Differences41.020
Preventing Chronic Disease41.020
Quaternary Research41.020
Western Journal of Medicine41.020
Transplantation Proceedings41.020
Trends in Amplification41.020
Ulster Medical Journal41.020
University of Pittsburgh Medical Center41.020
UpToDate41.020
Vaccine Research Center41.020
The AAPS Journal41.020
Finite Elements in Analysis and Design41.020
Linear Algebra and its Applications41.020
Annales de l'Institut Henri Poincare C41.020
Applied Mathematics Letters41.020
Applied Numerical Mathematics41.020
Current Opinion in Genetics & Development41.020
Journal of Fluency Disorders41.020
Nonlinear Analysis41.020
Nuclear Instruments & Methods in Physics Research B41.020
Rice41.020
Seminars in Cell & Developmental Biology41.020
Systems & Control Letters41.020
NeuroToxicology41.020
Differential Geometry and its Applications41.020
Journal of Combinatorial Theory, Series B41.020
Journal of Mathematical Analysis and Applications41.020
Journal of Web Semantics41.020
Pathophysiology41.020
BJOG: an International Journal of Obstetrics and Gynaecology41.020
Cancer Control41.020
Archives of Gerontology and Geriatrics41.020
Cryptogamie Bryologie41.020
Advances in Marine Biology41.020
BBA: Molecular Basis of Disease41.020
Global Finance Journal41.020
Advances in Carbohydrate Chemistry and Biochemistry41.020
AAPS PharmSciTech41.020
Brain and Development41.020
Cryptogamie Algologie41.020
Aggression and Violent Behavior41.020
Pediatric Neurology41.020
General Hospital Psychiatry41.020
Comparative Immunology, Microbiology & Infectious Diseases41.020
International Journal of Mental Health Systems41.020
Advances in Applied Microbiology41.020
Optometry - Journal of the American Optometric Association41.020
Journal of Policy Modeling41.020
Best Practice and Research: Clinical Gastroenterology41.020
International Journal of Law and Psychiatry41.020
Prostaglandins and Other Lipid Mediators41.020
Building and Environment41.020
Industrial Marketing Management41.020
Meat Science41.020
Research in Organizational Behavior41.020
Fish and Shellfish Immunology41.020
Journal of Immunological Methods41.020
Human Pathology41.020
Comparative Biochemistry and Physiology. Part A: Molecular and Integrative Physiology41.020
The History of the Family41.020
Journal of Environmental Management41.020
Insight41.020
Business Horizons41.020
Computers in Human Behavior41.020
Government Information Quarterly41.020
Linguistics and Education41.020
Cryptogamie Mycologie41.020
Behaviour Research and Therapy41.020
Advances in Botanical Research41.020
Journal of Urban Health41.020
Comptes Rendus. Géoscience41.020
Neural Development41.020
Socio-Economic Planning Sciences41.020
Organizational Dynamics41.020
The American Journal of Surgery41.020
Clinical Neurophysiology41.020
Ocean Engineering41.020
International Review of Law and Economics41.020
Nuclear Physics B - Proceedings Supplements41.020
Revue Europeene de Psychologie Appliquee41.020
Computers & Graphics41.020
Patient Care: Topics in Allergy and Immunology41.020
Journal of African Earth Sciences41.020
Journal of the Society of Laparoendoscopic Surgeons41.020
Annual Reports in Medicinal Chemistry41.020
Comparative Biochemistry and Physiology. Part D: Genomics and Proteomics41.020
European Journal of Mechanics A - Solids41.020
Computers and Composition41.020
Review of Financial Economics41.020
Maturitas41.020
Financial Services Review41.020
Mechanics Research Communications41.020
Journal of Cultural Heritage41.020
Clinical Imaging41.020
Journal of Environmental Sciences41.020
Journal of Clinical Lipidology41.020
Journal of Orthopaedics, Trauma and Rehabilitation41.020
Ticks and Tick-borne Diseases41.020
The Electricity Journal41.020
Social Science Research41.020
Archives of Cardiovascular Diseases Supplements41.020
HealthGrades41.020
National Survey of Family Growth41.020
National Vital Statistics System41.020
NIOSH Power Tools Database41.020
UCLA Health System41.020
Q2064174241.020
Advances in Nutrition41.020
Oregon Graduate Center41.020
Morbidity and Mortality Weekly Report: Recommendations and Reports41.020
Filtration & Separation41.020
Fundamental and Applied Toxicology41.020
Journal of the Less Common Metals41.020
Scripta Metallurgica41.020
Diseases of the chest41.020
Chemical health & safety American Chemical Society, Division of Chemical Health and Safety41.020
Revista paulista de pediatria : orgão oficial da Sociedade de Pediatria de São Paulo41.020
Behavioral Biology41.020
The Journal of clinical and aesthetic dermatology41.020
Alcohol research : current reviews41.020
Cell Biology International Reports41.020
Vital & health statistics. Series 3, Analytical and epidemiological studies41.020
Dermato-endocrinology41.020
British Heart Journal41.020
The western journal of emergency medicine41.020
Prostate international41.020
Psychiatry41.020
Mycobiology41.020
The Lancet Psychiatry41.020
Advances in food research41.020
Science in China. Series B, Chemistry, life sciences & earth sciences41.020
Genetic analysis, techniques and applications41.020
Journal of the American Pharmaceutical Association41.020
Vital and health statistics. Series 3, Analytical studies41.020
Vital and health statistics. Ser. 4, Documents and committee reports41.020
Vital and health statistics. Series 13, Data from the National Health Survey41.020
The Harvard mental health letter41.020
Journal of epilepsy41.020
Ethology and sociobiology41.020
Aging trends (Hyattsville, Md.)41.020
Clinical microbiology newsletter41.020
NCHS data brief41.020
Journal of Verbal Learning and Verbal Behavior41.020
Paediatrics and Child Health41.020
The Lancet: Diabetes & Endocrinology41.020
Avian Research41.020
Alzheimer's & dementia (Amsterdam, Netherlands)41.020
Cell Chemical Biology41.020
MMWR supplements41.020
Clinical neurophysiology practice41.020
Information and control41.020
Studies in Logic and the Foundations of Mathematics41.020
Computing systems in engineering : an international journal41.020
National Center for Emerging and Zoonotic Infectious Diseases41.020
Division of Parasitic Diseases and Malaria41.020
Advanced Dermatology & Cosmetic Surgery41.020
Chronic Disease Prevention and Health Promotion41.020
UPMC Health System41.020
UH Cleveland Medical Center41.020
The Journal of Finance and Data Science41.020
CaosDB - Research Data Management for Complex, Changing, and Automated Research Workflows41.020
Johns Hopkins Medicine41.020
Journal of Urban Management41.020
Journal of Asian Ceramic Societies41.020
Climate Risk Management41.020
Information Processing in Agriculture41.020
Advances in Inorganic Chemistry and Radiochemistry41.020
Fish Physiology41.020
Computer Vision, Graphics, and Image Processing41.020
Network Security41.020
Inorganic and Nuclear Chemistry Letters41.020
Inorganica Chimica Acta Reviews41.020
Information Storage and Retrieval41.020
bidirectional encoder representations from transformers41.020
Biometric Technology Today41.020
Membrane Technology41.020
Filtration Industry Analyst41.020
Fuel Cells Bulletin41.020
Journal of Patient Safety & Infection Control41.020
Pump Industry Analyst41.020
Space Research Today41.020
World Pumps41.020
Patient Education and Counseling40.111
Schweiger Dermatology Group (United States)40.111
La Roche-Posay40.006
Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis28.503
Atopic Dermatitis: Skin-Directed Management28.503
Activation of epidermal toll-like receptor 2 enhances tight junction function: implications for atopic dermatitis and skin barrier repair28.503
The first Australian Baseline Series: Recommendations for patch testing in suspected contact dermatitis28.503
Efficacy of a Moisturizing Foam in Skin Barrier Regeneration and Itch Relief in Subjects Prone to Atopic Dermatitis28.503
Case studies assessing a new skin barrier repair cream for the treatment of atopic dermatitis28.503
Patch testing with dermatophagoides and its correlation with chronic eczema and atopic dermatitis.28.503
Severe skin inflammation and filaggrin mutation similarly alter the skin barrier in patients with atopic dermatitis28.503
Sesquiterpene lactone mix patch testing supplemented with dandelion extract in patients with allergic contact dermatitis, atopic dermatitis and non-allergic chronic inflammatory skin diseases28.503
Sensitive skin is highly frequent in extrinsic atopic dermatitis and correlates with disease severity markers but not necessarily with skin barrier impairment28.503
Effects of Systematic Patient Education in Skin Care and Protection in a Hand Eczema Clinic28.503
Curing Atopic Dermatits in Children With a Commerical Medical Device and Maintaining Healthy Skin by Using a New Cosmetic Product28.503
Evaluation of skin barrier function in allergic contact dermatitis and atopic dermatitis using method of the continuous TEWL measurement28.503
Approaching atopic dermatitis treatment differently: from skin barrier preservation to allergen-specific immunotherapy28.503
Canadian Consensus on Skin Barrier Repair Therapy in Atopic Dermatitis28.503
The impact of dupilumab on patch testing and the prevalence of comorbid allergic contact dermatitis in recalcitrant atopic dermatitis: A retrospective chart review28.503
Variable impact of dupilumab on patch testing results and allergic contact dermatitis in adults with atopic dermatitis28.503
Factors influencing the occurrence of hand eczema in adults with a history of atopic dermatitis in childhood28.503
Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas28.503
Role of Antimicrobial Peptides in Skin Barrier Repair in Individuals with Atopic Dermatitis28.503
Exploring the relationship between allergic contact dermatitis and atopic dermatitis in children: insights from a retrospective patch testing analysis28.503
682 Induction of keratin 1 and keratin 10 expression by topical glucose in a mouse model of atopic dermatitis and in keratinocyte culture: A possible role of glucose in skin barrier repair28.503
atopic dermatitis22.602
rash22.602
miliaria22.602
hand eczema22.602
No7 product line22.602
Chemical assessment of "In-Use" allergic contact dermatitis patch test reagents from dermatology clinics22.602
Histamine and Skin Barrier: Are Histamine Antagonists Useful for the Prevention or Treatment of Atopic Dermatitis?22.602
Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis22.602
Epidermal Permeability Barrier Defects and Barrier Repair Therapy in Atopic Dermatitis22.602
Safety and efficacy of clocortolone pivalate 0.1 percent cream in the treatment of atopic dermatitis, contact dermatitis, and seborrheic dermatitis22.602
A review of perineal skin care protocols and skin barrier product use22.602
Contact allergies to topical corticosteroids: 10 cases of contact dermatitis22.602
Allergic contact dermatitis from topical corticosteroids22.602
Skin barrier homeostasis in atopic dermatitis: feedback regulation of kallikrein activity22.602
Skin Barrier Defects in Atopic Dermatitis22.602
Current trends in patch testing - new data from the German Contact Dermatitis Research Group (DKG) and the Information Network of Departments of Dermatology (IVDK).22.602
Anogenital dermatitis in patients referred for patch testing: retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 1994-2004.22.602
The value of patch testing patients with a scattered generalized distribution of dermatitis: retrospective cross-sectional analyses of North American Contact Dermatitis Group data, 2001 to 2004.22.602
An overview of the efficacy of topical corticosteroids in experimental human nickel contact dermatitis22.602
Histamine H1 and H2 receptor antagonists accelerate skin barrier repair and prevent epidermal hyperplasia induced by barrier disruption in a dry environment22.602
Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis.22.602
Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema22.602
Noninvasive measuring methods for the investigation of irritant patch test reactions. A study of patients with hand eczema, atopic dermatitis and controls22.602
Occupation-related contact dermatitis in North American health care workers referred for patch testing: cross-sectional data, 1998 to 2004.22.602
Contact allergy in children referred for patch testing: North American Contact Dermatitis Group data, 2001-2004.22.602
Aeroallergen patch testing in patients of suspected contact dermatitis22.602
CX₃CL1 (fractalkine) and its receptor CX₃CR1 regulate atopic dermatitis by controlling effector T cell retention in inflamed skin22.602
Atopic Dermatitis-like Graft-versus-host Disease and Lichen Planus-like Graft-versus-host Disease: Alterations in Skin Barrier Function and Related Molecules22.602
Abnormal skin barrier in the etiopathogenesis of atopic dermatitis22.602
Patient education in the long-term management of atopic dermatitis.22.602
Sensitive Skin: Assessment of the Skin Barrier Using Confocal Raman Microspectroscopy.22.602
Adhesion molecule profiles in atopic dermatitis vs. allergic contact dermatitis: pharmacological modulation by cetirizine22.602
Identification of cross-reaction patterns in allergic contact dermatitis from topical corticosteroids22.602
Patch testing with fragrances: results of a multicenter study of the European Environmental and Contact Dermatitis Research Group with 48 frequently used constituents of perfumes22.602
Efficacy of a lipid-based barrier repair formulation in moderate-to-severe pediatric atopic dermatitis22.602
Effect of standardized skin care regimens on neonatal skin barrier function in different body areas22.602
Patch testing in atopic dermatitis.22.602
Hepatitis Due to Mycophenolate Mofetil Used to Treat Atopic Dermatitis and Allergic Contact Dermatitis22.602
Patch testing in suspected allergic contact dermatitis to cosmetics22.602
Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention22.602
Effect of olive and sunflower seed oil on the adult skin barrier: implications for neonatal skin care22.602
A systematic review of contact dermatitis treatment and prevention22.602
Risk for hand eczema in employees with past or present atopic dermatitis22.602
Topically applied ZnO nanoparticles suppress allergen induced skin inflammation but induce vigorous IgE production in the atopic dermatitis mouse model22.602
The role of patch testing for chemical and protein allergens in atopic dermatitis.22.602
Extracellular vesicles derived from Staphylococcus aureus induce atopic dermatitis-like skin inflammation22.602
Objective assessment of topical corticosteroids and non-steroidal anti-inflammatory drugs in methyl-nicotinate-induced skin inflammation22.602
Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial22.602
Atopic dermatitis results in intrinsic barrier and immune abnormalities: Implications for contact dermatitis22.602
The utility of patch testing children with atopic dermatitis22.602
Toll-like receptor 3 activation is required for normal skin barrier repair following UV damage22.602
Filaggrin mutations may confer susceptibility to chronic hand eczema characterized by combined allergic and irritant contact dermatitis22.602
Dexpanthenol enhances skin barrier repair and reduces inflammation after sodium lauryl sulphate-induced irritation22.602
Atopic dermatitis: a disease of altered skin barrier and immune dysregulation22.602
The skin barrier and use of moisturizers in atopic dermatitis22.602
The relationship between atopic dermatitis and contact dermatitis22.602
Patch testing for allergic contact dermatitis in the allergist office22.602
A pilot study of emollient therapy for the primary prevention of atopic dermatitis22.602
Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year22.602
Review: Pathogenesis of canine atopic dermatitis: skin barrier and host-micro-organism interaction.22.602
Still elusive relationship between atopic dermatitis and allergic contact dermatitis.22.602
Pruni cortex ameliorates skin inflammation possibly through HMGB1-NFκB pathway in house dust mite induced atopic dermatitis NC/Nga transgenic mice22.602
Lessons from atopy patch testing in atopic dermatitis22.602
Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis.22.602
Stratum corneum pH in atopic dermatitis: impact on skin barrier function and colonization with Staphylococcus Aureus22.602
Multiple pathways driving IgE production and chronic dermatitis in mice: a model for atopic dermatitis?22.602
Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis22.602
Evaluation of the effect of a 0.0584% hydrocortisone aceponate spray on clinical signs and skin barrier function in dogs with atopic dermatitis22.602
Patch testing in Iranian children with allergic contact dermatitis22.602
A Pragmatic Approach to Patch Testing Atopic Dermatitis Patients: Clinical Recommendations Based on Expert Consensus Opinion.22.602
Do Early Skin Care Practices Alter the Risk of Atopic Dermatitis? A Case‐Control Study22.602
Pediatric Contact Dermatitis Registry Data on Contact Allergy in Children With Atopic Dermatitis22.602
Occupational Contact Dermatitis in North American Print Machine Operators Referred for Patch Testing: Retrospective Analysis of Cross-Sectional Data From the North American Contact Dermatitis Group 1998 to 2014.22.602
Occupational Contact Dermatitis in North American Production Workers Referred for Patch Testing: Retrospective Analysis of Cross-Sectional Data From the North American Contact Dermatitis Group 1998 to 2014.22.602
Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen22.602
Skin care education and individual counselling versus treatment as usual in healthcare workers with hand eczema: randomised clinical trial.22.602
Comparison of the efficacy and safety of 0.1% tacrolimus ointment with topical corticosteroids in adult patients with atopic dermatitis: review of randomised, double-blind clinical studies conducted in Japan22.602
Skin barrier function in atopic dermatitis22.602
Skin barrier function and dermal inflammation. An experimental study of transepidermal water loss after dermal tuberculin injection compared with SLS patch testing22.602
Barrier repair trumps immunology in the pathogenesis and therapy of atopic dermatitis22.602
A prospective study of atopic dermatitis managed without topical corticosteroids for a 6-month period22.602
NOD2 and TLR2 ligands trigger the activation of basophils and eosinophils by interacting with dermal fibroblasts in atopic dermatitis-like skin inflammation22.602
Atopic dermatitis, patch testing, and house dust mites: a brief review22.602
Gentle cleansing and moisturizing for patients with atopic dermatitis and sensitive skin22.602
Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption22.602
Expression of COUP-TF-interacting protein 2 (CTIP2) in human atopic dermatitis and allergic contact dermatitis skin22.602
Application of Topical Acids Improves Atopic Dermatitis in Murine Model by Enhancement of Skin Barrier Functions Regardless of the Origin of Acids22.602
Accumulation of Metal-Specific T Cells in Inflamed Skin in a Novel Murine Model of Chromium-Induced Allergic Contact Dermatitis22.602
Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: overview of the pathophysiology of atopic dermatitis22.602
Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment:keratinocytes in atopic dermatitis - their pathogenic involvement.22.602
Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: mechanisms and management of itch in atopic dermatitis22.602
Skin barrier breakdown: a renaissance in emollient therapy.22.602
An Appropriate Response to the Black-Box Warning: Corrective, Barrier Repair Therapy in Atopic Dermatitis.22.602
The effectiveness of a skin care program for the prevention of contact dermatitis in health care workers (the Healthy Hands Project): study protocol for a cluster randomized controlled trial22.602
The diagnostic value of atopy patch testing and prick testing in atopic dermatitis: facts and controversies22.602
Impact of atopic dermatitis and loss-of-function mutations in the filaggrin gene on the development of occupational irritant contact dermatitis22.602
Unravelling the skin barrier: a new paradigm for atopic dermatitis and house dust mites22.602
Skin barrier in atopic dermatitis.22.602
Quality of life and health-related utility analysis of adults with moderate and severe atopic dermatitis treated with tacrolimus ointment vs. topical corticosteroids22.602
Patch testing in atopic dermatitis patients.22.602
Atopic dermatitis: current options and treatment plan22.602
Current evidence of skin barrier dysfunction in human and canine atopic dermatitis22.602
The Antimicrobial Skin Barrier in Patients with Atopic Dermatitis22.602
Propylene glycol: an often unrecognized cause of allergic contact dermatitis in patients using topical corticosteroids22.602
Papulosquamous disorders: atopic dermatitis, psoriasis, seborrheic dermatitis, and nickel contact dermatitis22.602
Is the skin barrier abnormal in dogs with atopic dermatitis?22.602
Allergic contact dermatitis to nickel in children with atopic dermatitis22.602
Wet dressing therapy in conjunction with topical corticosteroids is effective for rapid control of severe pediatric atopic dermatitis: experience with 218 patients over 30 years at Mayo Clinic22.602
A multi-center, retrospective review of patch testing for contact dermatitis in allergy practices22.602
Therapeutic Patient Education in Children with Atopic Dermatitis: Position Paper on Objectives and Recommendations22.602
New Insights into Atopic Dermatitis: Role of Skin Barrier and Immune Dysregulation22.602
Barrier Repair Therapy in Atopic Dermatitis: An Overview22.602
Clinical relevance of skin barrier changes associated with the use of oral isotretinoin: the importance of barrier repair therapy in patient management22.602
Atopic dermatitis, and the role for a ceramide-dominant, physiologic lipid-based barrier repair emulsion22.602
Role of Th17 Cells in Skin Inflammation of Allergic Contact Dermatits22.602
Update on the Structure and Function of the Skin Barrier: Atopic Dermatitis as an Exemplar of Clinical Implications22.602
Basics of Patch Testing for Allergic Contact Dermatitis22.602
Skin barrier in atopic dermatitis.22.602
Immunological and molecular targets of atopic dermatitis treatment22.602
Skin Barrier and Immune Dysregulation in Atopic Dermatitis: An Evolving Story with Important Clinical Implications22.602
The Role of Contact Dermatitis in Patients with Atopic Dermatitis22.602
Current clinical practice in atopic dermatitis22.602
Eucalyptus oil: contact allergy and safety22.602
Skin pH Is the Master Switch of Kallikrein 5-Mediated Skin Barrier Destruction in a Murine Atopic Dermatitis Model22.602
Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?22.602
A Practical Guide to Patch Testing22.602
European Society of Contact Dermatitis guideline for diagnostic patch testing - recommendations on best practice22.602
EAACI position paper for practical patch testing in allergic contact dermatitis in children.22.602
Cortisol Homeostasis in the Epidermis is Influenced by Topical Corticosteroids in Patients with Atopic Dermatitis22.602
Countering Staphylococcus Overgrowth During Patch Testing in Children with Moderate to Severe Atopic Dermatitis22.602
Hataedock treatment has preventive therapeutic effects for atopic dermatitis through skin barrier protection in Dermatophagoides farinae-induced NC/Nga mice22.602
Efficacy and Tolerability of a Cosmetic Skin Care Product With Trans-4-t-butylcyclohexanol and Licochalcone A in Subjects With Sensitive Skin Prone to Redness and Rosacea22.602
The role of innate lymphoid cells in healthy and inflamed skin22.602
Stratum Corneum Lipids: Their Role for the Skin Barrier Function in Healthy Subjects and Atopic Dermatitis Patients.22.602
Biological Variation in Skin Barrier Function: From A (Atopic Dermatitis) to X (Xerosis).22.602
Coconut oil: The future of atopic dermatitis treatment?22.602
Anti-inflammatory and anti-allergic effects and underlying mechanisms of Huang-Lian-Jie-Du extract: Implication for atopic dermatitis treatment.22.602
Vitamin D in atopic dermatitis, chronic urticaria and allergic contact dermatitis22.602
Wet Wrap Therapy in Moderate to Severe Atopic Dermatitis22.602
Systematic review and meta-analysis of randomized clinical trials (RCTs) comparing topical calcineurin inhibitors with topical corticosteroids for atopic dermatitis: A 15-year experience22.602
Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march.22.602
Effects of structured patient education in adults with atopic dermatitis: Multicenter randomized controlled trial22.602
Skin barrier in atopic dermatitis: beyond filaggrin22.602
Skin Barrier Health: Regulation and Repair of the Stratum Corneum and the Role of Over-the-Counter Skin Care22.602
Efficacy and safety of wet wrap therapy for patients with atopic dermatitis: a systematic review and meta-analysis.22.602
Profile of skin barrier proteins and cytokines in adults with atopic dermatitis.22.602
Exogenous Factors in Skin Barrier Repair22.602
Efficacy of a Hand Regimen in Skin Barrier Protection in Individuals With Occupational Irritant Contact Dermatitis22.602
Efficacy of a Skin Condition-Adapted Solution for Xerosis and Itch Relief Associated With Aging22.602
Oleanolic acid acetate inhibits atopic dermatitis and allergic contact dermatitis in a murine model22.602
Patch testing, tuberculin testing and sensitization with dinitrochlorobenzene and nitrosodimethylanilini of patients with atopic dermatitis22.602
Atopic dermatitis treatment: Current state of the art and emerging therapies22.602
Contact dermatitis considerations in atopic dermatitis22.602
Hand eczema and long-term prognosis in atopic dermatitis22.602
Immunofluorescence of the skin in allergic diseases: an investigation of patients with contact dermatitis, allergic vasculitis and atopic dermatitis22.602
Facial eczema management protocols used on dairy farms in the North Island of New Zealand and associated concentrations of zinc in serum22.602
Is Food Allergy Testing Reliable in Pediatric Atopic Dermatitis? A Population-Based Study22.602
Impact of systemic alitretinoin treatment on skin barrier gene and protein expression in patients with chronic hand eczema22.602
Assessing the readability of skin care and pressure ulcer patient education materials22.602
Smokers report more psoriasis, but not atopic dermatitis or hand eczema: results from a Norwegian population survey among adults22.602
Patch testing with low molecular oligomers of epoxy resins in humans22.602
Patch testing and contact allergens in Ethiopia--results of 514 contact dermatitis patients using the European baseline series22.602
The value of patch testing: a review of 363 cases of allergic contact dermatitis.22.602
Epidermal Synthesis of Prostaglandins and their Effect on Levels of Cyclic Adenosine 3',5'-Monophosphate22.602
Atopic dermatitis: skin care and topical therapies22.602
IL-17 Receptor A Maintains and Protects the Skin Barrier To Prevent Allergic Skin Inflammation.22.602
Dual-functional transdermal drug delivery system with controllable drug loading based on thermosensitive poloxamer hydrogel for atopic dermatitis treatment.22.602
Staphylococcus aureus-derived membrane vesicles exacerbate skin inflammation in atopic dermatitis22.602
Attitudes of Australian dermatologists to the use and safety of topical corticosteroids in paediatric atopic dermatitis22.602
Patch testing with hydroxyisohexyl 3-cyclohexene carboxaldehyde (HICC) - a multicentre study of the Swedish Contact Dermatitis Research Group.22.602
Atopic dermatitis with severe facial lesions exacerbated by contact dermatitis from topical medicaments22.602
Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis22.602
Idiopathic CD4+ lymphocyte deficiency. Report of an unusual case associated with atopic dermatitis and allergic contact dermatitis and review of the literature22.602
Pilot Study to Evaluate the Effect of Topical Dimethicone on Clinical Signs and Skin Barrier Function in Dogs with Naturally Occurring Atopic Dermatitis22.602
Prevalence of atopic dermatitis, asthma, allergic rhinitis, and hand and contact dermatitis in adolescents. The Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis22.602
Down-regulation of IL-12 by topical corticosteroids in chronic atopic dermatitis.22.602
Clinical test with Apolar cream and Calmuril-hydrocortisone cream in contact dermatitis and atopic dermatitis22.602
Thymic stromal lymphopoietin and IL-33 promote skin inflammation and vaccinia virus replication in a mouse model of atopic dermatitis22.602
Onset and severity of atopic dermatitis, atopy and hand eczema in adolescents.22.602
Chronic finger dermatitis after trauma. Diagnosis: posttraumatic eczema with allergic contact dermatitis to neomycin, bacitracin, and topical corticosteroids22.602
Contact allergy to topical corticosteroids and systemic contact dermatitis from prednisolone with tolerance of triamcinolone.22.602
Fluocinonide vs halcinonide in atopic dermatitis. A paired comparison of two potent topical corticosteroids22.602
Pharmacists' knowledge about use of topical corticosteroids in atopic dermatitis: Pre and post continuing professional development education22.602
Profiles of selected nutrients affecting skin condition in children with atopic dermatitis22.602
Conditional knock out of N-WASP in keratinocytes causes skin barrier defects and atopic dermatitis-like inflammation22.602
Systemic antihistamines--a common outside the guidelines therapeutic strategy in hand eczema management.22.602
Patch testing for contact dermatitis.22.602
Effect of skin barrier emulsion cream vs a conventional moisturizer on transepidermal water loss and corneometry in atopic dermatitis: a pilot study22.602
Hand eczema and atopic dermatitis in adolescents: a prospective cohort study from the BAMSE project.22.602
Is atopic dermatitis a predisposing factor for experimental acute irritant contact dermatitis?22.602
Management of Patients with Atopic Dermatitis: The Role of Emollient Therapy22.602
The effect of long-term feeding of skin barrier-fortified diets on the owner-assessed incidence of atopic dermatitis symptoms in Labrador retrievers22.602
Allergic Contact Dermatitis: Patch Testing Beyond the TRUE Test.22.602
Repair and maintenance of the epidermal barrier in patients diagnosed with atopic dermatitis: an evaluation of the components of a body wash-moisturizer skin care regimen directed at management of atopic skin22.602
A Randomised Controlled Trial to evaluate the effect of a new skin care regimen on skin barrier function in those with podoconiosis in Ethiopia.22.602
Filaggrin loss-of-function mutations and atopic dermatitis as risk factors for hand eczema in apprentice nurses: part II of a prospective cohort study22.602
Topical steroids under wet-wrap dressings in atopic dermatitis--a vehicle-controlled trial22.602
Skin barrier defect in atopic dermatitis: increased permeability of the stratum corneum using dimethyl sulfoxide and theophylline22.602
TLR2 and TLR4 expression in atopic dermatitis, contact dermatitis and psoriasis22.602
Pyrrolidone carboxylic acid levels or caspase-14 expression in the corneocytes of lesional skin correlates with clinical severity, skin barrier function and lesional inflammation in atopic dermatitis22.602
A Characterization of the expression of 14-3-3 isoforms in psoriasis, basal cell carcinoma, atopic dermatitis and contact dermatitis22.602
Combined skin prick and patch testing enhances identification of peanut-allergic patients with atopic dermatitis22.602
Health-related utility among adults with atopic dermatitis treated with 0.1% tacrolimus ointment as maintenance therapy over the long term: findings from the Protopic CONTROL study22.602
Patch testing with egg represents a useful integration to diagnosis of egg allergy in children with atopic dermatitis22.602
Effects of a novel formulation of fluocinonide 0.1% cream on skin barrier function in atopic dermatitis22.602
Allergic contact dermatitis: patch testing results at Mount Sinai Medical Center22.602
Increased Th2 activity and diminished skin barrier function cooperate in allergic skin inflammation.22.602
Percutaneous absorption of potent topical corticosteroids in patients with severe atopic dermatitis22.602
Topical corticosteroids in atopic dermatitis22.602
Stratum corneum TARC level is a new indicator of lesional skin inflammation in atopic dermatitis.22.602
Patch testing in allergic contact dermatitis: is it useful to perform the cosmetic series in addition to the European standard series?22.602
Successful treatment of lichen amyloidosus associated with atopic dermatitis using a combination of narrowband ultraviolet B phototherapy, topical corticosteroids and an antihistamine22.602
Allergic contact dermatitis and systemic contact dermatitis in a patient with polysensitization to topical corticosteroids22.602
Semipermeable glove membranes--effects on skin barrier repair following SLS irritation22.602
Cost-effectiveness of a barrier-strengthening moisturizing cream as maintenance therapy vs. no treatment after an initial steroid course in patients with atopic dermatitis in Sweden--with model applications for Denmark, Norway and Finland22.602
Practical issues for emollient therapy in dry and itchy skin22.602
Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis22.602
Ultra-pure soft water improves skin barrier function in children with atopic dermatitis: a randomized, double-blind, placebo-controlled, crossover pilot study.22.602
Prevalence of foot eczema and associated occupational and non‐occupational factors in patients with hand eczema22.602
Human β-defensin-2 as a marker for disease severity and skin barrier properties in atopic dermatitis.22.602
Staphylococcal colonization in atopic dermatitis treatment with topical tacrolimus (Fk506).22.602
Propylene glycol allergic contact dermatitis. A quick reference guide for propylene glycol-free topical corticosteroids in Saudi Arabia22.602
Perforin and granzyme B may contribute to skin inflammation in atopic dermatitis and psoriasis22.602
Canine atopic dermatitis: a retrospective study of 266 cases examined at the University of California, Davis, 1992-1998. Part I. Clinical features and allergy testing results22.602
Exacerbation of allergic contact dermatitis from amcinonide triggered by patch testing22.602
Evaluation of efficacy of a skin lipid mixture in patients with irritant contact dermatitis, allergic contact dermatitis or atopic dermatitis: a multicenter study22.602
Induction of atopic dermatitis-like skin lesion in NC/Nga mice--the influence of the skin barrier destroying solution to the induction of dermatitis22.602
Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle22.602
The spectrum of allergic (cross-)sensitivity in clinical patch testing with 'para amino' compounds22.602
Patch testing for permanent-press allergic contact dermatitis22.602
Patch testing to exclude allergic contact dermatitis caused by povidone-iodine22.602
Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity22.602
Serum IgE levels in atopic dermatitis and in allergic contact dermatitis22.602
Hand eczema classification: a cross-sectional, multicentre study of the aetiology and morphology of hand eczema22.602
P2X purinergic receptor antagonist accelerates skin barrier repair and prevents epidermal hyperplasia induced by skin barrier disruption22.602
What's new in contact dermatitis: allergy to topical steroids in Israeli patients with contact dermatitis.22.602
Re-patch testing patients with long-term contact dermatitis22.602
Allergic Contact Dermatitis in Children With and Without Atopic Dermatitis22.602
Hydrocortisone-loaded poly(ε-caprolactone) nanoparticles for atopic dermatitis treatment.22.602
Recovery of a Pharmacologically Active Fatty Acid During the Inflammatory Reaction, Invoked by Patch Testing in Allergic Contact Dermatitis22.602
Influence of treating atopic dermatitis with oral antihistamine and topical steroids on selected parameters of cell and humoral immunity22.602
Results of patch testing to personal care product allergens in a standard series and a supplemental cosmetic series: an analysis of 945 patients from the Mayo Clinic Contact Dermatitis Group, 2000-2007.22.602
Electroporation and ultradeformable liposomes; human skin barrier repair by phospholipid22.602
The effect of combined topical steroids and habit-reversal treatment in patients with atopic dermatitis22.602
What do patients with occupational hand eczema know about skin care?22.602
Artificial disruption of skin barrier prior to irritant patch testing does not improve test design22.602
Detection of occupational allergic contact dermatitis by patch testing22.602
Survey of atopic dermatitis and skin barrier functions in Japanese and Chinese school students22.602
Patch testing of experimentally sensitized beagle dogs: development of a model for skin lesions of atopic dermatitis22.602
A holistic view on dermatitis: patch testing should be considered in patients with atopic dermatitis.22.602
Serum leptin level in children with atopic dermatitis-treated topical steroids22.602
Effect of semipermeable membranes on skin barrier repair following tape stripping22.602
Occupationally related contact dermatitis in North American food service workers referred for patch testing, 1994 to 2010.22.602
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial22.602
Iodopropynylbutyl carbamate 0.2% is suggested for patch testing of patients with eczema possibly related to preservatives22.602
Effect of pimecrolimus cream 1% on skin condition and sleep disturbance in children with atopic dermatitis22.602
Patch testing in children with hand eczema. A 5-year multicentre study in Spain22.602
Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial.22.602
Allergic contact dermatitis in hand eczema22.602
Atopic dermatitis and contact dermatitis in children22.602
Rutin suppresses atopic dermatitis and allergic contact dermatitis22.602
Impact of Patch Testing on Quality of Life in Patients with Hand Eczema: A Follow-up Study22.602
MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes.22.602
Daily intake of Jeju groundwater improves the skin condition of the model mouse for human atopic dermatitis22.602
The effect of topical corticosteroids on bone mineral density in adults with atopic dermatitis22.602
Atopic dermatitis, filaggrin mutations and irritant contact dermatitis.22.602
Skin care products can aggravate epidermal function: studies in a murine model suggest a pathogenic role in sensitive skin.22.602
Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis22.602
A review of the impact of patch testing on quality of life in allergic contact dermatitis22.602
Allergic contact dermatitis in Danish children referred for patch testing - a nationwide multicentre study22.602
Routine patch testing with frullanolide mix: an European Environmental and Contact Dermatitis Research Group multicentre study22.602
Patch testing in children from 2005 to 2012: results from the North American contact dermatitis group22.602
Prevalence and risk factors for allergic contact dermatitis to topical treatment in atopic dermatitis: a study in 641 children.22.602
Lesional elastase activity in psoriasis, contact dermatitis, and atopic dermatitis22.602
The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial22.602
Nurses' perceptions of the benefits and adverse effects of hand disinfection: alcohol-based hand rubs vs. hygienic handwashing: a multicentre questionnaire study with additional patch testing by the German Contact Dermatitis Research Group22.602
Poor compliance with topical corticosteroids for atopic dermatitis despite severe disease.22.602
Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study22.602
Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis: Reactivity to topical preservatives22.602
Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitis22.602
A method for identifying causative chemicals of allergic contact dermatitis using a combination of chemical analysis and patch testing in patients and animal groups: application to a case of rubber boot dermatitis22.602
Sensitizing potential of triclosan and triclosan-based skin care products in patients with chronic eczema22.602
Erythema multiforme-like eruption induced by contact dermatitis caused by topical corticosteroids22.602
Phenotypical characteristics of the immune cells in allergic contact dermatitis, atopic dermatitis and pityriasis rosea22.602
Inhibition of skin inflammation and atopic dermatitis by topical application of a novel ceramide derivative, K112PC-5, in mice22.602
Instant barrier repair: a pilot study investigating occlusion with a new hydrogel patch for the treatment of atopic dermatitis22.602
Contact dermatitis to pentylene glycol in a prescription cream for atopic dermatitis: case report22.602
Skin barrier dysfunction in atopic dermatitis22.602
StabiEL: stabilization of skin condition with Elidel--a patients' satisfaction observational study addressing the treatment, with pimecrolimus cream, of atopic dermatitis pretreated with topical corticosteroid22.602
Extracellular superoxide dismutase ameliorates house dust mite‐induced atopic dermatitis‐like skin inflammation and inhibits mast cell activation in mice22.602
Alleviating the itch-scratch cycle in atopic dermatitis22.602
Neuroimmunomodulatory compound for sensitive skin care: in vitro and clinical assessment22.602
Detection of contact hypersensitivity to corticosteroids in allergic contact dermatitis patients who do not respond to topical corticosteroids22.602
Value of patch testing in atopic dermatitis22.602
Patch testing for allergic contact dermatitis to cigarettes: Smoked/unsmoked components and formaldehyde factors22.602
Allergic and photoallergic contact dermatitis from ketoprofen: results of (photo) patch testing and follow-up of 42 patients22.602
Peroxisome proliferator-activated receptor alpha regulates skin inflammation and humoral response in atopic dermatitis22.602
A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis22.602
Opportunities for improving, adapting and introducing emollient therapy and improved newborn skin care practices in Africa22.602
Comparing the effect of bleach and water baths on skin barrier function in atopic dermatitis: a split‐body randomized controlled trial22.602
Xerosis is associated with atopic dermatitis, hand eczema and contact sensitization independent of filaggrin gene mutations22.602
A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.22.602
43 Role of Sweating on Impaired Skin Barrier Functions in Atopic Dermatitis.22.602
Comparison of atopy patch testing to skin prick testing for diagnosing mite-induced atopic dermatitis: a systematic review and meta-analysis.22.602
Importance of chamber size for the outcome of atopy patch testing in children with atopic dermatitis and food allergy22.602
Anti-Inflammatory and Skin Barrier Repair Effects of Topical Application of Some Plant Oils22.602
Red ginseng extracts attenuate skin inflammation in atopic dermatitis through p70 ribosomal protein S6 kinase activation22.602
Rapid, successful treatment of atopic dermatitis recalcitrant to topical corticosteroids.22.602
Therapeutic patient education in children with moderate to severe atopic dermatitis: A multicenter randomized controlled trial in China22.602
Anti-Inflammatory Activities of Pentaherbs Formula, Berberine, Gallic Acid and Chlorogenic Acid in Atopic Dermatitis-Like Skin Inflammation22.602
The Role and Diagnosis of Allergic Contact Dermatitis in Patients with Atopic Dermatitis22.602
Analysis of sensitive skin barrier function: basic indicators and sebum composition22.602
Patch testing for occupational allergens and the evaluation of patients with occupational contact dermatitis22.602
Patch testing in Israeli children with suspected allergic contact dermatitis: A retrospective study and literature review.22.602
Effect of Oral Administration of a Mixture of Probiotic Strains on SCORAD Index and Use of Topical Steroids in Young Patients With Moderate Atopic Dermatitis22.602
The association between atopic dermatitis and hand eczema: a systematic review and meta-analysis22.602
Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: possible contribution to skin inflammation22.602
Atopic Dermatitis Disease Education22.602
Atopic dermatitis treatment: what's new on the horizon?22.602
Atopy patch testing with aeroallergens in patients with atopic dermatitis and controls in Singapore22.602
Histamine H 4 Receptor Antagonists Ineffective against Itch and Skin Inflammation in Atopic Dermatitis Mouse Model22.602
Quality of life, anxiety, depression and obsessive‐compulsive tendencies in patients with chronic hand eczema22.602
Atopic dermatitis: correlation between non-damaged skin barrier function and disease activity22.602
Applying a vernix caseosa based formulation accelerates skin barrier repair by modulating lipid biosynthesis.22.602
The cystatin M/E-controlled pathway of skin barrier formation: expression of its key components in psoriasis and atopic dermatitis22.602
Histomorphology and Immunophenotype of Eczematous Skin Lesions Revisited-Skin Biopsies Are Not Reliable in Differentiating Allergic Contact Dermatitis, Irritant Contact Dermatitis, and Atopic Dermatitis22.602
Derivation, Evaluation, and Validation of Illustrations of Key Counselling Points for a Pediatric Eczema Action Plan.22.602
The Future of Atopic Dermatitis Treatment22.602
Patient education programs for childhood atopic dermatitis: who is interested?22.602
Interplay between the skin barrier and immune cells in patients with atopic dermatitis unraveled by means of mathematical modeling.22.602
Impaired responses of peripheral blood mononuclear cells to nickel in patients with nickel-allergic contact dermatitis and concomitant atopic dermatitis22.602
The integration of physiologically-targeted skin care in the management of atopic dermatitis: focus on the use of a cleanser and moisturizer system incorporating a ceramide precursor, filaggrin degradation products, and specific "skin-barrier-friend22.602
Gamisasangja-tang suppresses pruritus and atopic skin inflammation in the NC/Nga murine model of atopic dermatitis22.602
“Inflammatory skin march”: IL-1–mediated skin inflammation, atopic dermatitis, and psoriasis to cardiovascular events22.602
Establishing a Role for Interleukin-17 in Atopic Dermatitis-Related Skin Inflammation22.602
Randomized, double-blinded, placebo-controlled pilot study on the effects of topical blackcurrant emulsion enriched in essential fatty acids, ceramides and 18-beta glycyrrhetinic acid on clinical signs and skin barrier function in dogs with atopic d22.602
Occupational Contact Dermatitis in Mechanics and Repairers Referred for Patch Testing: Retrospective Analysis From the North American Contact Dermatitis Group 1998-2014.22.602
Parenting and childhood atopic dermatitis: A cross-sectional study of relationships between parenting behaviour, skin care management, and disease severity in young children.22.602
Effectiveness of the Healthy Skin Clinic--a randomized clinical trial of nurse-led patient counselling in hand eczema22.602
Therapeutic benefits in atopic dermatitis care from the patients' perspective: results of the German national health care study 'Atopic Health'.22.602
Allergic contact dermatitis caused by topical herbal remedies: importance of patch testing with the patients' own products.22.602
Effects of the Fruit Extract of Tribulus terrestris on Skin Inflammation in Mice with Oxazolone-Induced Atopic Dermatitis through Regulation of Calcium Channels, Orai-1 and TRPV3, and Mast Cell Activation.22.602
Health-Related Quality of Life, Patient Satisfaction, and Adherence to Treatment in Patients with Moderate or Severe Atopic Dermatitis on Maintenance Therapy: the CONDA-SAT Study22.602
Use of frozen poloxamer as a base for Itchy skin conditions, including irritant contact dermatitis22.602
Hand eczema, atopic dermatitis and filaggrin mutations in adult Danes: a registry-based study assessing risk of disability pension22.602
A novel JAK inhibitor JTE-052 reduces skin inflammation and ameliorates chronic dermatitis in rodent models: Comparison with conventional therapeutic agents.22.602
What's up dermatology? A pilot survey of the use of WhatsApp in dermatology practice and case discussion among members of WhatsApp dermatology groups.22.602
Atopic Dermatitis and Non-atopic Hand Eczema Have Similar Negative Impacts on Quality of Life: Implications for Clinical Significance22.602
Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accused22.602
Therapeutic patient education in atopic dermatitis: worldwide experiences.22.602
The role of interleukin-17 in mouse models of atopic dermatitis and contact dermatitis.22.602
Leukotriene receptor antagonism may not be effective in atopic dermatitis treatment after all.22.602
Detecting photoallergic contact dermatitis with patch testing and daylight.22.602
Chronic hand eczema: a prevalent and challenging skin condition22.602
Multicenter Patch Testing With Methylchloroisothizoline/Methylisothiazolinone in 100 and 200 ppm Within the International Contact Dermatitis Research Group22.602
Classification of hand eczema: clinical and aetiological types. Based on the guideline of the Danish Contact Dermatitis Group22.602
Multicenter Patch Testing With Methylisothiazolinone and Methylchloroisothiazolinone/Methylisothiazolinone Within the International Contact Dermatitis Research Group22.602
Atopic dermatitis, house dust mites, and patch testing22.602
Multicenter Patch Testing With a Resol Resin Based on Phenol and Formaldehyde Within the International Contact Dermatitis Research Group22.602
Signs of atopic dermatitis and contact dermatitis affected by distinct H2-haplotype in the NC/Nga genetic background22.602
Inhibitory Activity of Allergic Contact Dermatitis and Atopic Dermatitis-Like Skin in BALB/c Mouse through Oral Administration of Fermented Barks of Alnus sibirica22.602
A randomized, open-label study to evaluate an intermittent dosing regimen of fluticasone propionate 0.05% cream in combination with regular emollient skin care in reducing the risk of relapse in pediatric patients with stabilized atopic dermatitis22.602
Examination of the skin barrier repair/wound healing process using a living skin equivalent (LSE) model and matrix-assisted laser desorption-ionization-mass spectrometry imaging (MALDI-MSI).22.602
Influence of topical steroids on intraocular pressure in patients with atopic dermatitis22.602
Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE).22.602
Patient education for adults with atopic dermatitis according to the ARNE concept22.602
Dietary intake of glucono-δ-lactone attenuates skin inflammation and contributes to maintaining skin condition.22.602
Adherence in Atopic Dermatitis22.602
Biologic Therapy for Atopic Dermatitis: Moving Beyond the Practice Parameter and Guidelines22.602
SKIN BARRIER AND EPIDERMAL DENDRITIC CELLS IN ATOPIC DERMATITIS.22.602
THE BRIEF COMMENTARY ON GUIDELINES FOR THE MANAGEMENT OF ATOPIC DERMATITIS 2015 - FORCUSING ON THE BIOMARKER AND SKIN CARE.22.602
Identification of causative chemicals of allergic contact dermatitis using a combination of patch testing in patients and chemical analysis. Application to cases from industrial rubber products22.602
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a critical appraisal.22.602
Statement of the German Contact Dermatitis Research Group (DKG) and the German Dermatological Society (DDG) on liability issues associated with patch testing using a patient's own materials22.602
Allergic contact dermatitis caused by textile dyes mimicking atopic dermatitis22.602
Patch testing to a textile dye mix by the international contact dermatitis research group22.602
Patch testing with a textile dye mix in two concentrations - a multicentre study by the Swedish contact dermatitis research group.22.602
Occupational allergic contact dermatitis in a 2-year follow-up study: how well does the patient remember the result of patch testing?22.602
ASSESSMENT OF THE KNOWLEDGE AND ATTITUDES OF NURSES ON THE SKIN CONDITION AND TREATMENT OF DAMAGE22.602
Hand eczema guidelines based on the Danish guidelines for the diagnosis and treatment of hand eczema22.602
Routine patch testing in a dermatology clinic of a teaching hospital in Nigeria.22.602
CHRONIC DERMATITIS OF THE DORSUM OF THE FEET AND SHINS, DUE TO ALLERGIC CONTACT DERMATITIS TO LEATHER PRODUCTS22.602
Atopic dermatitis-like pruritic skin inflammation caused by feeding a special diet to HR-1 hairless mice22.602
Classification of hand eczema.22.602
Physician Survey Regarding Patient Nonattendance at Follow-up Appointments at a University-Affiliated Medical Dermatology Clinic22.602
Effects of time and recall of patch test results on quality of life (QoL) after testing. Cross-sectional study analyzing QoL in hand eczema patients 1, 5 and 10 years after patch testing22.602
Anxiety level and severity of skin condition predicts outcome of psychotherapy in atopic dermatitis patients22.602
Wet wrap therapy in children with moderate to severe atopic dermatitis in a multidisciplinary treatment program.22.602
As in Atopic Dermatitis, Nonlesional Skin in Allergic Contact Dermatitis Displays Abnormalities in Barrier Function and Ceramide Content22.602
Patch testing and Histopathology in Thai patients with hyperpigmentation due to Erythema dyschromicum perstans, Lichen planus pigmentosus, and Pigmented contact dermatitis22.602
Patch Testing for Evaluation of Hypersensitivity to Implanted Metal Devices: A Perspective From the American Contact Dermatitis Society.22.602
Chitin nanofibrils suppress skin inflammation in atopic dermatitis-like skin lesions in NC/Nga mice22.602
Patch testing in suspected allergic contact dermatitis due to Emla cream in haemodialyzed patients22.602
Correlation of skin barrier impairment in atopic dermatitis with aeroallergen sensitization22.602
Disposable nitrile gloves protect hairdressers from systemic exposure to paratoluenediamine22.602
New horny layer marker proteins for evaluating skin condition in atopic dermatitis22.602
Topical corticosteroids in atopic dermatitis and the risk of glaucoma and cataracts22.602
The study of human skin irritation of a novel herbal skin care product and ingredients by human single closed patch testing22.602
Topical Glucose Induces Claudin-1 and Filaggrin Expression in a Mouse Model of Atopic Dermatitis and in Keratinocyte Culture, Exerting Anti-inflammatory Effects by Repairing Skin Barrier Function22.602
MyD88 Contributes to Staphylococcal Enterotoxin B-Triggered Atopic Dermatitis-Like Skin Inflammation in Mice22.602
Effects of skin care with shower therapy on children with atopic dermatitis in elementary schools22.602
Significance of Skin Barrier Dysfunction in Atopic Dermatitis22.602
Eczematous skin reaction from patch testing with aeroallergens in atopic children with and without atopic dermatitis22.602
Ceramide analogue 14S24 ((S)-2-tetracosanoylamino-3-hydroxypropionic acid tetradecyl ester) is effective in skin barrier repair in vitro.22.602
Filaggrin null mutations and association with contact allergy and allergic contact dermatitis: results from a tertiary dermatology clinic.22.602
Epidermal Expression of Host Response Genes upon Skin Barrier Disruption in Normal Skin and Uninvolved Skin of Psoriasis and Atopic Dermatitis Patients22.602
TRPV1 antagonist can suppress the atopic dermatitis-like symptoms by accelerating skin barrier recovery22.602
Expression profile of cornified envelope structural proteins and keratinocyte differentiation-regulating proteins during skin barrier repair.22.602
Is new better than tried and tested? Topical atopic dermatitis treatment in context.22.602
Inflammation-induced alterations in the skin barrier function: implications in atopic dermatitis.22.602
Skin barrier impairment correlates with cutaneous Staphylococcus aureus colonization and sensitization to skin-associated microbial antigens in adult patients with atopic dermatitis22.602
Effects of a protein-free oat plantlet extract on microinflammation and skin barrier function in atopic dermatitis patients.22.602
Contact dermatitis and patch testing for the allergist22.602
Clinical, biophysical and immunohistochemical analysis of skin reactions to acute skin barrier disruption - a comparative trial between participants with sensitive skin and those with nonsensitive skin.22.602
Disrupted Skin Barrier is Associated with Burning Sensation after Topical Tacrolimus Application in Atopic Dermatitis22.602
Histamine Iontophoresis as in vivo Model to Study Human Skin Inflammation with Minimal Barrier Impairment: Pilot Study Results of Application of the Model to a Sensitive Skin Panel22.602
Eczematous skin reaction to atopy patch testing with cockroach in patients with atopic dermatitis.22.602
Persistent telangiectasia following patch testing with topical corticosteroids.22.602
Immune-mediated Skin Inflammation is Similar in Severe Atopic Dermatitis Patients With or Without Filaggrin Mutation22.602
Patch testing in children--recommendations of the German Contact Dermatitis Research Group (DKG).22.602
The Influence of Two Different Foam Creams on Skin Barrier Repair of Foot Xerosis: A Prospective, Double-Blind, Randomised, Placebo-Controlled Intra-Individual Study22.602
Natural peroxisome proliferator-activated receptor-alpha agonist cream demonstrates similar therapeutic response to topical steroids in atopic dermatitis22.602
An innovative oat-based sterile emollient cream in the maintenance therapy of childhood atopic dermatitis.22.602
Benefit-risk tradeoff preferences for chronic hand eczema treatments22.602
Use of a Canine Model of Atopic Dermatitis to Investigate the Efficacy of a CCR4 Antagonist in Allergen-Induced Skin Inflammation in a Randomized Study.22.602
Efficacy of proactive long-term maintenance therapy of canine atopic dermatitis with 0.0584% hydrocortisone aceponate spray: a double-blind placebo controlled pilot study22.602
Water resistance profile as a marker of skin barrier damage in atopic dermatitis patients.22.602
Effects of Blending Oil of Lavender and Thyme on Oxidative Stress, Immunity, and Skin Condition in Atopic Dermatitis Induced Mice22.602
Pinus densiflora bark extract ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis in NC/Nga mice by regulating Th1/Th2 balance and skin barrier function.22.602
Steroid-Free Over-the-Counter Eczema Skin Care Formulations Reduce Risk of Flare, Prolong Time to Flare, and Reduce Eczema Symptoms in Pediatric Subjects With Atopic Dermatitis22.602
An economic evaluation of patch testing in the diagnosis and management of allergic contact dermatitis*122.602
Impact of patch testing on dermatology-specific quality of life in patients with allergic contact dermatitis*122.602
Correlation of clinical features and skin barrier function in adolescent and adult patients with atopic dermatitis22.602
A three-cohort comparison with videodermatoscopic evidence of the distinct homogeneous bushy capillary microvascular pattern in psoriasis vs atopic dermatitis and contact dermatitis22.602
The effects of using a moldable skin barrier on peristomal skin condition in persons with an ostomy: results of a prospective, observational, multinational study22.602
Prescribing success: Developing an integrated prescription and eczema action plan for atopic dermatitis.22.602
Patch Testing in Children and Adolescents With Suspected Allergic Contact Dermatitis22.602
A relationship between a psychosomatic and a skin condition in patients with atopic dermatitis22.602
Long-term efficacy of tacrolimus ointment for recalcitrant facial erythema resistant to topical corticosteroids in adult patients with atopic dermatitis22.602
Contact allergy to topical corticosteroids: a screening study with a corticosteroid mix. Portuguese Contact Dermatitis Research Group (GPEDC).22.602
Allergic contact dermatitis to topical corticosteroids: clobetasol propionate and clobetasone butyrate22.602
The antimicrobial protein psoriasin (S100A7) is upregulated in atopic dermatitis and after experimental skin barrier disruption.22.602
Molecular diagnostics of psoriasis, atopic dermatitis, allergic contact dermatitis and irritant contact dermatitis.22.602
Immunoglobulin- and complement-bearing lymphocytes in allergic contact dermatitis and atopic dermatitis (eczema).22.602
Long-term emollient therapy improves xerosis in children with atopic dermatitis.22.602
Noninvasive monitoring of plant-based formulations on skin barrier properties in infants with dry skin and risk for atopic dermatitis22.602
Emollient use alters skin barrier and microbes in infants at risk for developing atopic dermatitis22.602
Abnormal skin barrier in the etiopathogenesis of atopic dermatitis22.602
Lactic acid sting test does not differentiate between facial and generalized skin functional impairment in sensitive skin in atopic dermatitis and rosacea22.602
Guideline-Based Medicine Grading based upon the Guidelines of Care for Ambulatory Atopic Dermatitis Treatment in the United States22.602
Contact Dermatitis in Atopic Dermatitis Children-Past, Present, and Future22.602
Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity22.602
Application of moisturizer to neonates prevents development of atopic dermatitis22.602
Filaggrin null-mutations increase the risk and persistence of hand eczema in subjects with atopic dermatitis: results from a general population study22.602
Focus group parental opinions regarding treatment with topical corticosteroids on children with atopic dermatitis22.602
Long-term Likelihood of Patch Testing, Academic Practice, and American Contact Dermatitis Society Membership Among North American Alexander Fisher Award Winners From 1989 to 201222.602
Atypical Skin Inflammation in a 2.5-Year-Old Girl With Atopic Dermatitis22.602
Topical corticosteroids for treatment-resistant atopic dermatitis22.602
Relationship of ceramide–, and free fatty acid–cholesterol ratios in the stratum corneum with skin barrier function of normal, atopic dermatitis lesional and non-lesional skins22.602
Immunophenotyping of the cutaneous cellular infiltrate after atopy patch testing in cats with atopic dermatitis22.602
Animal Models for Retinoid Receptor Research: Implications for Epidermal Homeostasis, Skin Barrier Function, Wound Healing, and Atopic Dermatitis22.602
Moisturizers versus Current and Next-Generation Barrier Repair Therapy for the Management of Atopic Dermatitis22.602
Patch testing in hand eczema at a tertiary care center22.602
Topical administration of EGF suppresses immune response and protects skin barrier in DNCB-induced atopic dermatitis in NC/Nga mice22.602
Statistical analysis plan for the Healthy Hands Project; single centre cluster-randomised clinical trial of a skin care program for the prevention of contact dermatitis in health care workers22.602
Allergic or irritant contact dermatitis after patch testing with alcohol - that is the point22.602
Skin Barrier Function in Healthy Subjects and Patients with Atopic Dermatitis in Relation to Filaggrin Loss-of-Function Mutations22.602
Breach Delivery: Increased Solute Uptake Points to a Defective Skin Barrier in Atopic Dermatitis22.602
Patch Testing with Formaldehyde 2.0% in Parallel with 1.0% by the Swedish Contact Dermatitis Research Group22.602
Multicentre patch testing with methylisothiazolinone by the European Environmental and Contact Dermatitis Research Group22.602
Patch testing with methylchloroisothiazolinone/methylisothiazolinone 200 ppm aq. detects significantly more contact allergy than 100 ppm. A multicentre study within the European Environmental and Contact Dermatitis Research Group22.602
Skin care in occupational contact dermatitis of the hands22.602
A mechanistic target of rapamycin complex 1/2 (mTORC1)/V-Akt murine thymoma viral oncogene homolog 1 (AKT1)/cathepsin H axis controls filaggrin expression and processing in skin, a novel mechanism for skin barrier disruption in patients with atopic d22.602
Contact allergy to topical corticosteroids in children with atopic dermatitis22.602
Influence of Oral Administration of Lactic Acid Bacteria Metabolites on Skin Barrier Function and Water Content in a Murine Model of Atopic Dermatitis22.602
The additive value of patch testing with patients' own products at an occupational dermatology clinic22.602
Delay in medical attention to hand eczema: a follow-up study22.602
Heritability of Hand Eczema Is Not Explained by Comorbidity with Atopic Dermatitis22.602
Keratinocyte Expression of A20/TNFAIP3 Controls Skin Inflammation Associated with Atopic Dermatitis and Psoriasis22.602
Ghrelin protects against contact dermatitis and psoriasiform skin inflammation by antagonizing TNF-α/NF-κB signaling pathways22.602
Using Patch Testing to Improve Therapeutic Outcome in the Treatment of Hand Eczema in Vietnamese Patients22.602
Pathophysiological Study of Allergic Contact Dermatitis to Para-Phenylenediamine (PPD). Analysis of Cellular and Molecular Targets in Skin Inflammation22.602
Comparing Aquaphor to Atopiclair and EpiCeram in Children With Mild to Moderate Atopic Dermatitis22.602
A Study to Investigate the Use of Hydrogel Vehicle in Maintaining the Skin Barrier in Persons With Atopic Dermatitis22.602
Physicians' perceptions of an eczema action plan for atopic dermatitis22.602
Bleach Bath Treatment of Adults With Atopic Dermatitis22.602
The effect of tacrolimus compared with betamethasone valerate on the skin barrier in volunteers with quiescent atopic dermatitis22.602
The effect of aqueous cream BP on the skin barrier in volunteers with a previous history of atopic dermatitis22.602
Clinical and Cytological Effects of Pimecrolimus Cream 1% after Resolution of Active Atopic Dermatitis Lesions by Topical Corticosteroids: A Randomized Controlled Trial22.602
Seal, Stopping Atopic Dermatitis and Allergy Study22.602
A minimally invasive tool to study immune response and skin barrier in children with atopic dermatitis22.602
A Study to Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis22.602
A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis22.602
A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis22.602
A Study of Baricitinib (LY3009104) in Combination With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis22.602
A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis22.602
A NOVel Moisturiser for Atopic Dermatitis: Effect on the Skin Barrier22.602
Improving Therapeutic Patient Education for Atopic Dermatitis: Evaluation of a Parent Handbook22.602
Comparing Cetaphil Restoraderm System Versus Standard Skin Care in Infants22.602
The Effects of Emollient Therapy on the Skin Barrier22.602
Pimecrolimus and Epidermal Barrier Function22.602
Clinical Analysis of the Influence of Using the Skin Care Products on the Diaper Area in Comparison With Using a Cotton Wool Cloth, Moistened With Clear Water on the Skin Physiology of the Newborns From the 1st Day to the 4th Week of Life22.602
Eczema Action Plan Improves Patient and Caregiver Understanding and Perception of Atopic Dermatitis Management22.602
Effect of Resveratrol-Enriched Rice on Skin Inflammation and Pruritus in the NC/Nga Mouse Model of Atopic Dermatitis22.602
Patch Testing in Allergic Contact Dermatitis over the Lower Extremities22.602
Repeat patch testing in a patient with allergic contact dermatitis improved on dupilumab22.602
PEBBLES study protocol: a randomised controlled trial to prevent atopic dermatitis, food allergy and sensitisation in infants with a family history of allergic disease using a skin barrier improvement strategy22.602
A Study to Test Safety and Tolerability of a Study Drug Called MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Patients With Moderate to Severe Atopic Dermatitis22.602
Tralokinumab in Combination With Topical Corticosteroids in Subjects With Severe Atopic Dermatitis Who Are Not Adequately Controlled With or Have Contraindications to Oral Cyclosporine A22.602
A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Ad22.602
The Effect of Diluted Sodium Hypochlorite Solution and Moisturizers on Skin Barrier Function in Atopic Dermatitis22.602
The Effect of Lipopolysaccharide-containing Moisturizing Cream on Skin Care in Patients With Mild Atopic Dermatitis22.602
Test to Determine the Effectiveness of Moisturizing Balm Used on Babies With Dry, Itchy Skin22.602
Effect of Holly Mangrove Shower Gel in Atopic Dermatitis Patients22.602
Study to Assess the Safety of Dupilumab (REGN668/SAR231893) Administered Concomitantly With Topical Corticosteroids (TCS) in Patients With Moderate-to-severe Atopic Dermatitis (AD)22.602
Study of Apremilast in Atopic or Contact Dermatitis22.602
Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis22.602
Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis22.602
VANOS Cream and Skin Barrier Function22.602
Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Allergic Skin Inflammation (P03475)22.602
An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis22.602
Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)22.602
Clinical vs. Anecdotal Evidence - Pediatric Atopic Dermatitis22.602
Efficacy of Topical Coal Tar in Children With Atopic Dermatitis22.602
Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3 (ECZema TRAlokinumab Trial no. 3)22.602
Skin barrier function in patients with completely healed atopic dermatitis22.602
A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis22.602
A Study in Participants With Psoriatic Arthritis Attending Dermatology Clinics22.602
A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis22.602
A Study to Assess CLn® BodyWash for Reducing Skin Fauna in Patients With Hand Eczema22.602
Assessing the Impact of Pioglitazone on Skin Barrier Function in Atopic Dermatitis Patients22.602
Trial to Determine the Therapeutic Benefit of an OTC Cream on Dry, Itchy Skin of Adults and Children With Eczema22.602
Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients22.602
Atopic Dermatitis (AD) and Food Allergy22.602
A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists22.602
Atopic Dermatitis in Atopy Predisposed Infants22.602
An RCT to Evaluate the Effect of a New Skin Care Regimen on SBF in Those With Podoconiosis22.602
An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical Corticosteroids22.602
A Test to Determine the Usefulness and Safety of a Cream Used on Babies With Dry Itchy Skin22.602
Patch testing with pollens of Gramineae in patients with atopic dermatitis and mucosal atopy22.602
Cytokinetics of epidermal and dermal cells in allergic contact dermatitis and atopic dermatitis (author's transl)22.602
Allergic contact dermatitis from topical steroids22.602
Allergic contact dermatitis in atopic dermatitis22.602
Topical corticosteroids and Staphylococcus aureus in atopic dermatitis22.602
Cyclosporin maintenance therapy for severe atopic dermatitis22.602
Lack of efficacy of topical cyclosporin A in atopic dermatitis and allergic contact dermatitis22.602
Allergic contact dermatitis from multiple topical corticosteroids22.602
Allergic contact dermatitis due to ingredients of vehicles. A "vehicle tray" for patch testing22.602
IgE-positive epidermal Langerhans cells in allergic contact dermatitis lesions provoked in patients with atopic dermatitis22.602
Interrelationship between biliary dyskinesia and chronic urticaria, chronic eczema and atopic dermatitis22.602
Epidermal class II human lymphocyte antigen expression in atopic dermatitis: a comparison with experimental allergic contact dermatitis22.602
Hand eczema: an evaluation of the frequency of atopic background and the difference in clinical pattern between patients with and without atopic dermatitis22.602
Sodium cromoglycate in childhood atopic dermatitis treatment22.602
Patch testing in atopic dermatitis22.602
Behavior of eosinophilic granulocytes in skin exudates in contact dermatitis, urticaria and atopic dermatitis (skin window technic)22.602
Professional hand eczema and atopic dermatitis22.602
[The dermatophytic flora surveyed at the Dermatology Clinic of the Tottori University Hospital from 1981 to 1984--statistic analysis of the patients of various clinical types and a comparative study of the ratios of T. rubrum/T. mentagrophytes at de22.602
Intermittent maintenance therapy in chronic hand eczema with clobetasol propionate and flupredniden acetate22.602
Determination of suitable concentrations for patch testing of various fragrance materials. A summary of a group study conducted over a 6-year period. Mid-Japan Contact Dermatitis Research Group22.602
Prevalence of respiratory symptoms in children with atopic dermatitis attending pediatric dermatology clinics22.602
Contact dermatitis. XVI. Patch testing?22.602
Efficacy versus systemic effects of six topical steroids in the treatment of atopic dermatitis of childhood22.602
Increased "in vivo" lymphocyte blastogenesis in the peripheral blood of patients with atopic dermatitis and allergic contact dermatitis22.602
Patch testing for contact dermatitis22.602
Combined skin prick and patch testing enhances identification of food allergy in infants with atopic dermatitis22.602
Hand eczema in children with atopic dermatitis: a low prevalence?22.602
Atopic dermatitis, nickel sensitivity and xerosis as risk factors for hand eczema in women22.602
A retrospective evaluation of patch testing in patients diagnosed with allergic contact dermatitis22.602
Enhancement of in vitro spontaneous IgE production by topical steroids in patients with atopic dermatitis22.602
Improvement of skin barrier function during treatment of atopic dermatitis22.602
Coexistence of contact urticaria and contact dermatitis due to pearl oysters in an atopic dermatitis patient22.602
Contact allergy to aeroallergens in children with atopic dermatitis: comparison with allergic contact dermatitis22.602
Aeroallergen patch testing for patients presenting to contact dermatitis clinics22.602
Contact dermatitis due to topical steroids with conceivable cross reactions between topical steroid preparations22.602
Human and economic impact of allergic contact dermatitis and the role of patch testing22.602
Allergen specificity and endothelial transmigration of T cells in allergic contact dermatitis and atopic dermatitis are associated with the cutaneous lymphocyte antigen22.602
Identification of causative chemicals of allergic contact dermatitis using a combination of patch testing in patients and chemical analysis. Application to cases from rubber gloves22.602
Ranitidine treatment of hand eczema in patients with atopic dermatitis: a double-blind, placebo-controlled trial22.602
Identification of causative chemicals of allergic contact dermatitis using a combination of patch testing in patients and chemical analysis. Application to cases from rubber footwear22.602
Airborne contact dermatitis from chromate in cement with recall dermatitis on patch testing22.602
Allergic contact dermatitis and patch testing in childhood22.602
Contact dermatitis from thimerosal. 2 years' experience with ethylmercuric chloride in patch testing thimerosal-sensitive patients22.602
Pseudo-atopic dermatitis. Contact dermatitis due to chrome sensitivity simulating atopic dermatitis22.602
Treatment of atopic dermatitis in children: the importance of skin care and environmental control22.602
Squamometry in rating the efficacy of topical corticosteroids in atopic dermatitis22.602
Skin care and topical steroids22.602
Topical steroids for atopic dermatitis in primary care22.602
Why do patients with atopic dermatitis refuse to apply topical corticosteroids?22.602
Do topical steroids reduce relapses in adults with atopic dermatitis?22.602
Patch testing with the European standard series and Compositae extracts in patients with airborne contact dermatitis22.602
Impairment of skin barrier function in NC/Nga Tnd mice as a possible model for atopic dermatitis22.602
Patient education for adults with chronic eczema22.602
Patch testing with zinc dibenzyldithiocarbamate. A multicentre study of the Information Network of Departments of Dermatology and the German Contact Dermatitis Research Group22.602
Quantitative analysis of tryptase- and chymase-containing mast cells in atopic dermatitis and nummular eczema22.602
The results of ingredient patch testing in contact dermatitis elicited by povidone-iodine preparations22.602
Estimating dilutions for patch testing skin care products: A practical method22.602
Elevated serum levels of soluble CD30 are associated with atopic dermatitis, but not with respiratory atopic disorders and allergic contact dermatitis22.602
Occupational contact dermatitis in nurses with hand eczema22.602
Expression of 27 KD, 65 KD and 72/73 KD heat shock protein in atopic dermatitis: comparison with those in normal skin and contact dermatitis22.602
Effect of Ectoin Dermatitis Cream 7% on Skin Hydration and Skin Barrier Function22.602
Patch testing of nickel sulfate and potassium dichromate with a standardized ready-to-use test system gives highly reproducible results: a double-blind multicentre study22.602
Patch testing and aeroallergen intradermal testing in suspected allergic contact dermatitis, unclassified endogenous eczema and non-atopic chronic urticaria22.602
New insights into the role of T cells in atopic dermatitis and allergic contact dermatitis22.602
Contact dermatitis versus atopic dermatitis22.602
Reimbursement for patch testing at academic centers: the Achilles' heel of academic contact dermatitis specialists22.602
Contact dermatitis, nummular eczema, pompholyx; the most common dermatoses of the hands, their diagnosis, differential diagnosis and specific treatment22.602
The use of decision-analytical modelling in economic evaluation of patch testing in allergic contact dermatitis22.602
Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm)22.602
Expression of CD30 on T helper cells in the inflammatory infiltrate of acute atopic dermatitis but not of allergic contact dermatitis22.602
The effect of two moisturisers on skin barrier damage in allergic contact dermatitis22.602
Patch testing with maleopimaric acid in an occupational dermatology clinic22.602
AN EVALUATION OF HAND ECZEMA TREATMENT WITH FLUOCINOLONE ACETONIDE CREAM, AND FLUOCINOLONE ACETONIDE CREAM AND GRENZ RAY22.602
Patch testing in allergic contact dermatitis caused by topical Chinese herbal medicine22.602
Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis22.602
Compare the Skin Barrier Repair Function of Two Ceramide Containing Moisturizers22.602
Audit of prescribing practices of topical corticosteroids in outpatient dermatology clinics in north Palestine22.602
Results of standard series patch testing in patients with occupational allergic contact dermatitis22.602
Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis22.602
[Topical steroids and tacrolimus for the treatment of atopic dermatitis]22.602
The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study22.602
Dynamics of skin barrier repair following topical applications of miconazole nitrate22.602
Allergic contact dermatitis mimicking atopic dermatitis due to enoxolone in a topical medicament22.602
Smad3 signal transducer regulates skin inflammation and specific IgE response in murine model of atopic dermatitis22.602
Prevalence and morphology of hand eczema in patients with atopic dermatitis22.602
Allergic contact dermatitis from corticosteroids: reproducibility of patch testing and correlation with intradermal testing22.602
Contact dermatitis; practical management and identification of cause without patch testing22.602
The skin barrier, atopic dermatitis and allergy: a role for Langerhans cells?22.602
Patient education. Itch--skin care management22.602
Etiology and prognosis of hand eczema in a dermatology clinic in China: a follow-up study22.602
Emollients improve treatment results with topical corticosteroids in childhood atopic dermatitis: a randomized comparative study22.602
Development of numerous nerve fibers in the epidermis of hairless mice with atopic dermatitis-like pruritic skin inflammation22.602
Expression of CCR2 on monocytes and macrophages in chronically inflamed skin in atopic dermatitis and psoriasis22.602
Noninvasive biophysical assessments of the efficacy of a moisturizing cosmetic cream base for patients with atopic dermatitis during different seasons22.602
Genetics of skin barrier impairment in atopic dermatitis22.602
Atopic dermatitis and skin barrier function22.602
A survey of traditional Chinese medicine use in children with atopic dermatitis attending a paediatric dermatology clinic22.602
Allergic contact dermatitis and the endocannabinoid system: from mechanisms to skin care22.602
Contact hypersensitivity to topical corticosteroids--frequency of positive reactions in patch-tested patients with allergic contact dermatitis22.602
The new scoring system for evaluation of skin inflammation extent and severity in patients with atopic dermatitis22.602
Allergic contact dermatitis from natural rubber latex in atopic dermatitis and the risk of later Type I allergy22.602
The use of topical corticosteroids in atopic dermatitis in children22.602
Should topical antibacterials be routinely combined with topical steroids in the treatment of atopic dermatitis?22.602
Allergic contact dermatitis in patients with atopic dermatitis: A clinical study22.602
Hand eczema -- clinical patterns and role of patch testing22.602
An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids22.602
Relevance of patch testing in hand eczema--comment22.602
The effect of pimecrolimus on expression of genes associated with skin barrier dysfunction in atopic dermatitis skin lesions22.602
Dynamics of skin barrier repair following preconditioning by a biotechnology-driven extract from samphire (Crithmum maritimum) stem cells22.602
Predictors of clinical success in a multidisciplinary model of atopic dermatitis treatment22.602
Effects of "Skin Care School," a parental education program on childhood atopic dermatitis conducted during short hospitalization stays22.602
Patch testing in allergic contact dermatitis22.602
Patch testing practices of American Contact Dermatitis Society members22.602
Japanese cedar pollen as an exacerbation factor in atopic dermatitis: results of atopy patch testing and histological examination22.602
Impairment of skin barrier function is not inherent in atopic dermatitis patients: a prospective study conducted in newborns22.602
Skin barrier defects in atopic dermatitis: new treatments?22.602
Efficacy of sweat-antigen-inactivating skin care products on itching of patients with atopic dermatitis22.602
Response to treatment with oral alitretinoin in patients with chronic hand eczema that is refractory to treatment with potent topical corticosteroids: experience in 15 patients22.602
Multicentre Patch Testing with Compositae Mix by the Swedish Contact Dermatitis Research Group22.602
Topically applied semaphorin 3A ointment inhibits scratching behavior and improves skin inflammation in NC/Nga mice with atopic dermatitis22.602
Noninvasive Stratum Corneum Sampling and Electron Microscopical Examination of Skin Barrier Integrity: Pilot Study with a Topical Glycerin Formulation for Atopic Dermatitis22.602
Two-year assessment of effect of topical corticosteroids on bone mineral density in adults with moderate to severe atopic dermatitis22.602
IL-25 induces both inflammation and skin barrier dysfunction in atopic dermatitis22.602
Allergic contact dermatitis caused by dihydroxyacetone - optimal concentration and vehicle for patch testing22.602
Usefulness of skin-prick tests in children with hand eczema: comparison with their use in childhood and adult eczema22.602
Oral Lactobacillus paracasei improves skin barrier function recovery and reduces local skin inflammation22.602
New treatments for restoring impaired epidermal barrier permeability: Skin barrier repair creams22.602
Beclomethasone dipropionate: a second chance for topical steroids as maintenance therapy in ileal Crohn's disease22.602
Exacerbation of atopic dermatitis upon alkaline skin care22.602
Patient education to enhance contact dermatitis evaluation and testing22.602
Oral administration of glucosylceramide ameliorates inflammatory dry-skin condition in chronic oxazolone-induced irritant contact dermatitis in the mouse ear22.602
Kinetics and differential expression of the skin-related chemokines CCL27 and CCL17 in psoriasis, atopic dermatitis and allergic contact dermatitis22.602
Characteristics of patients with hand dermatitis referred to the contact dermatitis unit of a tertiary hospital and impact of patch testing on diagnosis22.602
Contact dermatitis and atopic dermatitis--rare comorbidity?22.602
The effect of damaged skin barrier induced by subclinical irritation on the sequential irritant contact dermatitis22.602
Patch testing in allergic contact dermatitis from minoxidil22.602
Is soybean patch testing a valid diagnostic tool for adult atopic dermatitis? A comparison of two methods22.602
Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor22.602